TNL Mediagene (TNMG) AI Stock Analysis

• Market Cap: $7.41M
• Dividend Yield: N/A
• Average Volume (3M): 11.02M
• Price to Earnings (P/E): ―
• Beta (1Y): 3.23
• Revenue Growth: 4.59%
• EPS Growth: -920.22%
• Country: US
• Employees: 500
• Sector: Healthcare
• Sector Strength: 45
• Industry: Publishing
• EPS (TTM): N/A
• Shares Outstanding: 2,555,793
• 10 Day Avg. Volume: 12,249,583
• 30 Day Avg. Volume: 11,015,397
• PEG Ratio: >-0.01
• Price to Book (P/B): 5.35
• Price to Sales (P/S): 4.01
• P/FCF Ratio: -18.89
• Enterprise Value/Market Cap: 3.09
• Enterprise Value/Revenue: 0.38
• Enterprise Value/Gross Profit: 1.38
• Enterprise Value/Ebitda: -0.31
• 1Y Price Target: $14.00
• Price Target Upside: 382.76% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $3.00 ▲(3.45% Upside)
• Action: Upgraded Date: 01/17/26
• Date: Action: Upgraded 01/17/26

The score is primarily held down by very weak financial performance—severe losses, negative cash flow, and elevated leverage despite strong revenue growth. Technicals add downside risk given the broader downtrend (below key longer-term moving averages and negative MACD). Valuation is also constrained by ongoing losses (negative P/E) and no dividend support.

Positive Factors

Revenue Growth

A 35.3% year-over-year revenue increase in 2024 shows durable demand for TNL’s digital content and advertising services. Strong top-line momentum supports scale effects, audience monetization, and provides a base to invest in product, content, or sales capabilities that can improve long-term profitability if cost structure is addressed.

Positive Equity Buffer

Maintaining positive stockholders’ equity provides a meaningful capital buffer against continued losses. That equity position helps preserve access to debt and equity markets, supports creditor confidence, and gives management flexibility to pursue restructuring or strategic initiatives without immediate insolvency risk.

Near-term Financing Support

The $1.6667M tranche with an 18-month maturity and six-month payment pause supplies near-term liquidity and runway. Structured convertible financing reduces immediate cash interest burden and gives management time to execute operational improvements or revenue initiatives, improving short-to-medium term solvency prospects.

Negative Factors

Severe Profitability Shortfall

Extremely negative EBIT and net margins indicate core operations destroy value relative to revenue. Such deep losses erode equity, limit reinvestment capacity, force recurring external financing, and raise execution risk for any growth strategy until meaningful margin improvement is achieved.

Negative Cash Conversion

Consistent negative operating cash flow and declining free cash flow show the company cannot convert revenues into sustaining cash. This reduces financial resilience, increases reliance on dilutive or expensive financing, and constrains the ability to fund strategic investments or reduce leverage over the medium term.

Governance, Listing and Leverage Risk

Being under a one-year Nasdaq Discretionary Panel Monitor, combined with a high reported debt-to-equity ratio (63.6%) and a recent auditor change tied to internal control concerns, raises regulatory, governance and refinancing risks that can restrict capital access and strategic flexibility if not resolved.

TNL Mediagene Business Overview & Revenue Model

Company Description

TNL Mediagene operates as a media company in Taiwan and Japan. The company operates The News Lens, a news site; Business Insider Japan, a news site focused on developments inside and outside Japan in business, finance, politics, and technology; Business Yee, a specialized Chinese-language business news site; DIGIDAY JAPAN, a publication for Japanese and international digital marketing news; MASHING UP, a conference and event series; Modern Retail, a site for retail marketing; Becoming Aces; and GLOSSY JAPAN, a site for beauty and fashion industry. It also operates Gizmodo Japan, a weblog site that publishes news, reviews, and buying guides of latest technology and consumer gadgets; Cool3c, a weblog site featuring new product information, reviews, and analysis of brand stories in gadget and tech space; Tech Insider, a site publishing stories on technology and business of technology; INSIDE, an online news publication focused on internet and software startups, blockchain, technology industry trends, digital life, and future technology. The company offers iCook, a food site; Lifehacker Japan, a weblog site about lifestyle advice, and software tips and news; ROOMIE, a site offering lifestyle items and ideas; ROOMIE KITCHEN, a cooking site; Life Insider Japan and Money Insider Japan sites for providing updates on work, lifestyles and personal finance; every little d, a design and art themed online publication; iGood for shopping; Sports Vision, a site that presents news and analysis on sports, athletes, sports policy, and business of sports; Agent Movie, a film and TV related news and review site; Fuze, a digital culture site publishing content focused on art, music, and counterculture in the digital age; and Sirabee, a news site that publishes articles on entertainment, gourmet, breaking news topics, and original research. It also involved artificial intelligence, advertising technology, digital studio, and e-commerce activities. The company is based in Tokyo, Japan.

How the Company Makes Money

TNMG generates revenue through multiple streams, primarily by offering subscription-based services, licensing agreements for its proprietary content, and advertising partnerships. The company has established significant collaborations with healthcare providers and educational institutions, providing tailored content solutions that meet specific sector needs. Additionally, TNMG monetizes its digital platforms through targeted advertising, leveraging user data analytics to optimize ad placements and maximize revenue potential.

TNL Mediagene Financial Statement Overview

Summary

Revenue growth is strong (2024 up 35.3% YoY), but financial quality is very weak: deeply negative profitability (EBIT margin -157.4%, net margin -175.3%), negative EBITDA/net income, and negative operating and free cash flow. Leverage is also elevated (debt-to-equity 63.6%) with negative ROE, indicating high risk and limited financial resilience.

Income Statement

TNL Mediagene's income statement reveals significant challenges. The company has experienced a rapid increase in total revenue year-over-year, with a notable increase of 35.3% in 2024 compared to 2023. However, this growth is overshadowed by substantial losses, exemplified by a negative EBIT margin of -157.4% and a net profit margin of -175.3% for 2024. The company faces profitability issues, which are further highlighted by negative EBITDA and net income, indicating operational inefficiencies and potential risks in sustaining growth.

Balance Sheet

The balance sheet of TNL Mediagene highlights a mixed financial position. While the company has managed to maintain a positive stockholders' equity in 2024, the debt-to-equity ratio is concerning at 63.6%, suggesting high leverage. The equity ratio stands at 39.2%, indicating moderate reliance on equity financing. However, the return on equity is negative due to consistent net losses, raising concerns about the company's ability to generate returns for shareholders.

Cash Flow

TNL Mediagene's cash flow statement underscores substantial cash management issues. The operating cash flow is negative, reflecting challenges in generating sufficient cash from operations. The company has a negative free cash flow growth rate, exacerbating liquidity concerns. Additionally, the free cash flow to net income ratio is unfavorable, indicating that the company struggles to convert its net income into positive cash flow, raising red flags about its financial health.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	60.57M	48.49M	35.84M	20.01M
Gross Profit	16.54M	17.74M	12.65M	7.74M
EBITDA	-73.81M	-73.92M	1.33M	-10.01M
Net Income	-83.41M	-85.00M	-804.98K	-11.01M
Balance Sheet
Total Assets	86.05M	92.92M	119.62M	26.53M
Cash, Cash Equivalents and Short-Term Investments	1.90M	3.65M	3.03M	3.91M
Total Debt	20.24M	23.14M	17.59M	6.71M
Total Liabilities	51.19M	56.51M	47.25M	50.67M
Stockholders Equity	34.86M	36.40M	72.62M	-25.30M
Cash Flow
Free Cash Flow	-11.21M	-10.30M	-1.68M	-1.04M
Operating Cash Flow	-11.13M	-10.21M	-1.42M	-760.11K
Investing Cash Flow	475.34K	947.95K	252.74K	-2.36M
Financing Cash Flow	9.21M	10.00M	530.97K	4.99M

TNL Mediagene Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TNMG, the sentiment is Negative. The current price of 2.9 is below the 20-day moving average (MA) of 2.97, below the 50-day MA of 3.00, and below the 200-day MA of 7.08, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 45.66 is Neutral, neither overbought nor oversold. The STOCH value of 38.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TNMG.

TNL Mediagene Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CNET	44 Neutral	$2.52M	-0.88	-50.26%	―	-66.59%	67.63%
DRCT	43 Neutral	$2.21M	-0.01	―	―	-62.46%	-12.90%
TNMG	41 Neutral	$7.41M	-0.05	-164.27%	―	4.59%	-920.22%
FTRK	41 Neutral	$10.03M	―	―	―	―	―
VSME	31 Underperform	$3.49M	-0.85	-194.72%	―	-11.51%	74.52%

TNL Mediagene Corporate Events

TNL Mediagene Regains Nasdaq Bid-Price Compliance but Faces One-Year Listing Monitor

On January 20, 2026, TNL Mediagene received confirmation from Nasdaq that it had regained compliance with the exchange’s minimum bid price requirement, after the company’s ordinary shares closed at or above $1.00 for 15 consecutive trading days between December 23, 2025, and January 14, 2026. While this removes the immediate risk to its Nasdaq Capital Market listing following a December 19, 2025 panel decision, Nasdaq has placed the company under a one-year Discretionary Panel Monitor, under which any future breach of continued listing standards during the monitoring period would trigger an automatic delisting determination without the usual cure or compliance grace periods, raising the stakes for management and shareholders as the group works to maintain long-term compliance.

The most recent analyst rating on (TNMG) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on TNL Mediagene stock, see the TNMG Stock Forecast page.

TNL Mediagene Wins Conditional Nasdaq Listing Extension Pending $1 Bid Price Compliance

On December 23, 2025, TNL Mediagene was informed by a Nasdaq Hearings Panel that its request for continued listing on the Nasdaq Capital Market had been granted, provided it regains compliance with Nasdaq’s $1 bid price requirement (Listing Rule 5550(a)(2)) by January 7, 2026 and promptly reports any material events that could affect that compliance. The conditional reprieve follows a November 6, 2025 staff determination to delist the stock for failure to meet the $1 bid price threshold after a 180-day grace period, TNL Mediagene’s appeal and hearing request on November 13, 2025, and a December 16, 2025 panel hearing at which the company presented its remediation plan, including a reverse share split announced on December 19; the shares will remain traded on Nasdaq pending the panel’s final written decision after the January 7 deadline, underscoring a critical near-term milestone for investors and the company’s U.S. listing status.

The most recent analyst rating on (TNMG) stock is a Sell with a $0.13 price target. To see the full list of analyst forecasts on TNL Mediagene stock, see the TNMG Stock Forecast page.

TNL Mediagene Announces 1-for-20 Reverse Split to Restore Nasdaq Compliance

On December 19, 2025, TNL Mediagene announced it will implement a 1-for-20 share consolidation of its ordinary shares, following shareholder approval on December 2, 2025 and board approval of the final ratio on December 9, 2025. The reverse split, which is expected to take effect for trading on a split-adjusted basis on the Nasdaq Capital Market on December 23, 2025 under the same ticker “TNMG” with a new CUSIP, will reduce the number of outstanding ordinary shares from 51,115,851 to approximately 2,555,793, with fractional shares rounded up and all shareholders’ percentage ownership largely preserved. The move is aimed at lifting the company’s per-share trading price to restore compliance with Nasdaq’s $1.00 minimum bid requirement and to broaden its appeal among institutional investors, while triggering proportional adjustments to the exercise or conversion terms of outstanding warrants, earnout shares, equity awards, and other equity instruments, signaling an effort to stabilize its listing status and strengthen its capital markets profile.

The most recent analyst rating on (TNMG) stock is a Sell with a $0.27 price target. To see the full list of analyst forecasts on TNL Mediagene stock, see the TNMG Stock Forecast page.

TNL Mediagene Amends Note Agreement and Issues Second Tranche

On December 8, 2025, TNL Mediagene amended its securities purchase agreement with 3i, LP, issuing a second tranche convertible note valued at $1,666,667. This amendment introduces revised terms for future note issuances, including an 18-month maturity, no installment payments for the first six months, and a cap on acceleration linked to trading volume. Additionally, TNL Mediagene issued a five-year warrant to purchase ordinary shares, exercisable under specific conditions, further solidifying its financial strategy and potentially impacting its market positioning and investor relations.

The most recent analyst rating on (TNMG) stock is a Sell with a $0.27 price target. To see the full list of analyst forecasts on TNL Mediagene stock, see the TNMG Stock Forecast page.

TNL Mediagene Announces Shareholder Meeting Results and Strategic Changes

On December 5, 2025, TNL Mediagene announced the results of its Annual General Meeting of Shareholders held on December 2, 2025. The meeting, initially convened on November 25, 2025, saw all proposals approved, including an increase in authorized share capital, amendments to the company’s memorandum and articles of association, and the election of new directors. These changes are expected to impact the company’s governance and operational strategies, potentially influencing its market positioning and stakeholder interests.

The most recent analyst rating on (TNMG) stock is a Sell with a $0.27 price target. To see the full list of analyst forecasts on TNL Mediagene stock, see the TNMG Stock Forecast page.

TNL Mediagene Appoints New Auditor Amid Internal Control Concerns

TNL Mediagene, a company operating in the media industry, announced a change in its certifying accountant. On October 9, 2025, PricewaterhouseCoopers, Taiwan, declined to stand for re-election as the independent registered public accounting firm for the company. Subsequently, on November 20, 2025, TNL Mediagene appointed Marcum Asia CPAs LLP as its new independent registered public accounting firm. This change follows a careful evaluation process and was approved by the audit committee of the board of directors. The transition is significant as it addresses material weaknesses in the company’s internal controls over financial reporting, which were noted in previous fiscal years.

The most recent analyst rating on (TNMG) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on TNL Mediagene stock, see the TNMG Stock Forecast page.